Effects of Pulsed Electromagnetic Fields on the Proliferation of Lymphocytes from Aids Patients, HIV-Seropositive Subjects, and Seronegative Drug Users

References

• Cantini M., Cossarizza A., Bersani F., Cadossi R., Ceccherelli G., Tenconi R., Gatti C., Franceschi C. Enhancing effects of low frequency pulsed electromagnetic fields on lectin-induced human lymphocyte proliferation. J. Bioelectricity 1986; 5: 91–104
   Web of Science ®Google Scholar
• Cadossi R., Emilia G., Torelli G., Ceccherelli G., Ferrari S., Ruggieri P. The effect of low frequency pulsing electromagnetic fields on the response of human normal lymphocytes to phytohemagglutinin. Bioelectrochem. Bioenergetics 1985; 14: 115–119
   Web of Science ®Google Scholar
• Cadossi R., Ceccherelli G., Emilia G., Torelli G., Ruggieri P., Bersani F., Cossarizza A., Franceschi C. The effects of low frequency pulsing electromagnetic fields on the response of human lymphocytes to lectins. Bioelectrochem. Bioenergetics 1988; 19: 315–322
   Web of Science ®Google Scholar
• Cossarizza A., Monti D., Bersani F., Cantini M., Cadossi R., Sacchi A., Franceschi C. Extremely low frequency pdsed electromagnetic fields increase cell proliferation in lymphocytes from young and aged subjects. Biochem. Biophys. Res. Commun. 1989; 160: 692–698
   PubMed Web of Science ®Google Scholar
• Emilia G., Torelli G., Ceccherelli G., Donelli A., Ferrari S., Zucchini P., Cadossi R. Effect of low-frequency, low-energy pulsing electromagnetic fields on response to lectin stimulation of human normal and chronic lymphocytic leukemia lymphocytes. J. Bioelectricity 1985; 4: 145–161
   Web of Science ®Google Scholar
• Cossarizza A., Monti D., Cantini M., Paganelli R., Monti agnani G., Cadossi R., Bersani F., Franceschi C. Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in lymphocytes from aged subjects. FEBS Lett. 1989; 248: 141–144
   PubMed Web of Science ®Google Scholar
• Gallo R.C., Sarin P.S., Gelmann E.P., Robert-Guroff M., Richardson E., Kalyaranaram A., Mann D., Sidhu G.D., Stahl R.E., Zolla-Pazner S., Leibowitch J., Popovic M. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome. Science 1983; 220: 865–867
   PubMed Web of Science ®Google Scholar
• Barre'-Sinoussi F., Chermann J.C., Fey F., Nugeyre M.T., Charmaret S., Gruest J., Dauget C., Axler-Blin C., Vezinet-Brun F., Rouziow C., Rozenbaum W., Montagnier L. Isolation of a T-lymphotropic retrovirus from patients at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868–871
   PubMed Web of Science ®Google Scholar
• Dalglish A.G., Beverley P.C.L., Clapham P.R., Crawford D.H., Greaves M.D., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312: 763–765
   PubMed Web of Science ®Google Scholar
• McDougal J.S., Maddon P.J., Dalgleish A.G., Clapham P.R., Littman D.R., Godfrey M., Maddon D.E., Chess L., Weiss R.A., Axel A. The T4 glycoprotein is a cell-surface receptor for the AIDS virus. Cold Spring Harbor Symposia on Quantitative Biology 1986; Vol. LI: 703–711
   Google Scholar
• Murray H.W., Rubin B.J., Masur H., Roberts R. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N. Engl. J. Med. 1984; 310: 883–889
   PubMed Web of Science ®Google Scholar
• Ebert C.E., Stoll D.B., Cassens B.J., Lipshutz W.H., Hauptman S.P. Diminished interleukin 2 production and receptor generation characterize the acquired immunodeficiency syndrome. Clin. Immunol. Immunopathol. 1985; 37: 283–297
   PubMedGoogle Scholar
• Centers for Disease Control. Characterization System for HTLV III/LAV Associated Virus Infections. Morbidity and Mortality Weekly Report 1986; 35: 334–339
   PubMedGoogle Scholar
• McLeod B.R., Pilla A.A., Sampsel M.W. Electromagnetic fields induced by Helmholtz aiding coils inside saline-filled boundaries. Bioelectromagnetics 1983; 4: 357–370
   PubMed Web of Science ®Google Scholar
• Böyum A. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 1968; 21(suppl. 97)77–91
   PubMed Web of Science ®Google Scholar
• Franceschi C., Licastro F., Chiricolo M., Bonetti F., Zannotti M., Fabris N., Mocchegiani E., Fantini M.P., Paolucci P., Masi M. Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome. J. Immunol. 1981; 126: 2161–2164
   PubMed Web of Science ®Google Scholar
• Uchiyama T., Broder S., Waldmann T.A. A monoclonal antibody (anti-TAC) reactive with activated and functionally mature human T cells. J. Immunol. 1981; 126: 1395–1397
   Web of Science ®Google Scholar
• Kung P.C., Goldstein G., Reinherz E.L., Schlossman S.F. Monoclonal antibodies defining distinctive human T cell surface antigens. Science 1979; 206: 347–349
   PubMed Web of Science ®Google Scholar
• Ko H.S., Fu S.M., Winchester R.J., Yu D.T.Y., Kunkel H.G. Ia determinants on stimulated human cells. J. Exp. Med. 1979; 150: 246–255
   PubMed Web of Science ®Google Scholar
• Ceuppens J.L., Goodwin J.S., Searles R.P. The presence of Ia antigen on human peripheral blood T cells and T cell subsets: Analysis with monoclonal antibodies and the fluorescence activated cell sorter. Cell. Immunol. 1981; 64: 277–294
   PubMed Web of Science ®Google Scholar
• Bassett C.A.L., Pawluk R.J., Pilla A.A. Augmentation of bone repair by inductively coupled pulsed electromagnetic fields. Science 1974; 184: 575–577
   PubMed Web of Science ®Google Scholar
• Barker A.T., Dixon R.A., Sharrard W.J.W., Sutcliffe M.L. Pulsed magnetic field therapy for tibia1 non-union: Interim results of a double-blind control assessment. Lancet 1984; i: 695–698
   Google Scholar
• Cossarizza A., Zannotti M., Montagnani G., Mussini D., Licastro F., Chiricolo M., Monti D., Ortolani C., Masi M., Franceschi C. Precocious aging of the immune system in Down's syndrome (DS). Proceedings of the Meeting of the European Group for Immunodeficiencies, 111, ViterboItaly, Sept., 11–131988
   Google Scholar